mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.4 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.4 |
mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |